This information was published on 2025-01-10T00:01:06 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2086390 (IR 1535732) |
| (220) |
06 May 2020
|
| (500) |
Provisions of paragraph 44(3)(b) and/or Reg 4.15A(3)(b) applied.
|
| (511) (510) |
Class 9
Computer software to program medical devices and apparatus for neurostimulation of the central and peripheral nervous system, computer software to program medical devices and apparatus for delivering neuromodulation therapy for the management of chronic, intractable pain and to provide therapy via closed loop stimulation; all of the aforesaid for the treatment of chronic pain, movement disorders, Chron’s disease, rheumatoid arthritis, diabetes, Raynaud’s phenomenon, incontinence / bladder disorders, faecal incontinence, non-obstructive urinary retention, constipation, chronic inflammatory conditions, depression, migraine, stroke rehabilitation, spinal cord injury, and none relating to seizure or epileptiform activity monitoring, nor apparatus for producing oxygen, oxygenators, oxygen concentrators, pulse oximeters |
| (540) | CLARITY |
| (550) | Word |
| (730) |
Saluda Medical Pty Ltd
|
| (750) |
FB Rice Pty Ltd
|
Find out more about publications on the About page.